https://www.healio.com/news/hematology-oncology/20231228/combination-yields-promising-pfs-outcomes-in-certain-patients-with-breast-cancer
0
0
12/28/23 at 5:16pm
Organization
Healio
Authors
SAN ANTONIO — The combination of zanidatamab, palbociclib and fulvestrant yielded promising PFS results among adults with HER2-positive/hormone receptor-positive metastatic breast cancer, findings from a phase 2A study showed. A primary analysis of the …
Create an account
or login to join the discussion